Akimichi Morita (A Morita)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 135

Top Venues

The Journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Yayoi Tada, Jia Guan, Ryoko Iwasaki, Akimichi Morita
Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database. The Journal of dermatology 51 (3) (2024)
Hiroshi Kato, Shinji Kano, Maki Yoshimitsu, Yua Nakagawa, Yukiko Yasui, Motoki Nakamura, Akimichi Morita
Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma. The Journal of dermatology (2024)
Akimichi Morita, H W Lim, T Passeron, C L Goh, H Y Kang, F Ly, J Ocampo-Candiani, S Puig, S Schalka, L Wei, A L Demessant, C Le Floc'h, D Kerob, B Dreno, J Krutmann
Attitudes and behaviors regarding sun exposure in Japan compared to Europe and North America. The Journal of dermatology 51 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Thierry Passeron, Brigitte Dreno, Susana Puig, Chee Leok Goh, Hee Young Kang, Fatimata Ly, Akimichi Morita, Jorge Ocampo Candiani, Sergio Schalka, Liu Wei, Anne-Laure Demessant-Flavigny, Caroline Le Floc'h, Delphine Kerob, Henry W Lim, Jean Krutmann
Outdoor workers and sun exposure: Results of an international survey on sun exposure behaviours and knowledge among 17 countries, the HELIOS project. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Yayoi Tada, Jia Guan, Ryoko Iwasaki, Akimichi Morita
Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database. The Journal of dermatology (2024)
Akimichi Morita, Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, A E J Gibson, Frauke Becker, Nataliya Bogoeva, Mamitaro Ohtsuki
Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Shinji Kano, Hiroshi Kato, Akimichi Morita
Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression. Experimental dermatology 33 (3) (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology (2024)
Yuki Enomoto, Yoshifumi Kanayama, Kyoko Ikumi, Mai Sakurai, Aya Yamamoto, Akimichi Morita
Cigarette smoking is an independent risk factor for developing vitiligo on the hands. Photodermatology, photoimmunology & photomedicine 40 (1) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Bruce E Strober, Andrew Blauvelt, Richard B Warren, Kim A Papp, April W Armstrong, Kenneth B Gordon, Akimichi Morita, Andrew F Alexis, Mark Lebwohl, Peter Foley, Renata M Kisa, Elizabeth Colston, Tao Wang, Subhashis Banerjee, Diamant Thaçi
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology 51 (7) (2024)
Yayoi Tada, Jia Guan, Ryoko Iwasaki, Akimichi Morita
Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database. The Journal of dermatology 51 (3) (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Bruce E Strober, Andrew Blauvelt, Richard B Warren, Kim A Papp, April W Armstrong, Kenneth B Gordon, Akimichi Morita, Andrew F Alexis, Mark Lebwohl, Peter Foley, Renata M Kisa, Elizabeth Colston, Tao Wang, Subhashis Banerjee, Diamant Thaçi
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Hiroshi Kato, Yohei Kawaguchi, Kenta Saito, Shuzo Hamamoto, Ryota Nakamura, Kazuki Ohashi, Shuhei Kondo, Atsushi Nakamura, Akimichi Morita
Differences in the clinical presentation of necrotizing fasciitis depending on the causative pathogen. The Journal of dermatology (2024)
Akimichi Morita, H W Lim, T Passeron, C L Goh, H Y Kang, F Ly, J Ocampo-Candiani, S Puig, S Schalka, L Wei, A L Demessant, C Le Floc'h, D Kerob, B Dreno, J Krutmann
Attitudes and behaviors regarding sun exposure in Japan compared to Europe and North America. The Journal of dermatology (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Bruce E Strober, Andrew Blauvelt, Richard B Warren, Kim A Papp, April W Armstrong, Kenneth B Gordon, Akimichi Morita, Andrew F Alexis, Mark Lebwohl, Peter Foley, Renata M Kisa, Elizabeth Colston, Tao Wang, Subhashis Banerjee, Diamant Thaçi
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Yuka Nojiri, Motoki Nakamura, Tetsuya Magara, Aya Yamamoto, Kyoko Ikumi, Reiko Nakamura, Emi Nishida, Thomas Haarmann-Stemmann, Akimichi Morita
Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients. Scientific reports 13 (1) (2023)
Yukiko Atsumi, Manami Toriyama, Hiroko Kato, Motoki Nakamura, Akimichi Morita, Masayuki Takaishi, Kaori Saito, Miku Tanaka, Fumihiro Okada, Makoto Tominaga, Ken J Ishii, Fumitaka Fujita
Anti-Inflammatory Role of TRPV4 in Human Macrophages. ImmunoHorizons 7 (1) (2023)
Thierry Passeron, H W Lim, C L Goh, H Y Kang, F Ly, Akimichi Morita, Jorge Ocampo Candiani, S Puig, S Schalka, L Wei, A L Demessant, C Le Floc'h, D Kerob, Brigitte Dreno, Jean Krutmann
"Do regrets of parents about sun overexposure impact preventive measures applied on their children? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Alexander A Navarini, Jörg C Prinz, Akimichi Morita, Tsen Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Yukiko Atsumi, Manami Toriyama, Hiroko Kato, Motoki Nakamura, Akimichi Morita, Masayuki Takaishi, Kaori Saito, Miku Tanaka, Fumihiro Okada, Makoto Tominaga, Ken J Ishii, Fumitaka Fujita
Anti-Inflammatory Role of TRPV4 in Human Macrophages. ImmunoHorizons 7 (1) (2023)
Akimichi Morita, Hidehisa Saeki
Pediatric psoriasis: Understanding pathological conditions and advances in treatment. The Journal of dermatology (2023)
Chee Leok Goh, Hee Young Kang, Akimichi Morita, Chengfeng Zhang, Yan Wu, Cita Rosita Sigit Prakoeswa, Nguyen Huu Sau, Delphine Kerob, Frederic Flament, Liu Wei
Awareness of sun exposure risks and photoprotection for preventing pigmentary disorders in Asian populations: Survey results from three Asian countries and expert panel recommendations. Photodermatology, photoimmunology & photomedicine (2023)
Alexander A Navarini, Jörg C Prinz, Akimichi Morita, Tsen Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Akimichi Morita, Hidehisa Saeki
Pediatric psoriasis: Understanding pathological conditions and advances in treatment. The Journal of dermatology 51 (2) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Yuka Nojiri, Motoki Nakamura, Tetsuya Magara, Aya Yamamoto, Kyoko Ikumi, Reiko Nakamura, Emi Nishida, Thomas Haarmann-Stemmann, Akimichi Morita
Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients. Scientific reports 13 (1) (2023)
Yayoi Tada, Akimichi Morita, Keiichi Yamanaka, Michihiro Kono, Shinichi Imafuku, Yukari Okubo, Fumikazu Yamazaki, Taisuke Kawamura, Asako Itakura, Mamitaro Ohtsuki
Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY). The Journal of dermatology (2023)
Akimasa Sanagawa, Tomoaki Hayakawa, Emi Nishida, Aya Yamamoto, Kyoko Ikumi, Yukari Mori, Yuji Hotta, Kazunori Kimura, Yoko Furukawa-Hibi, Akimichi Morita
Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma. The Journal of dermatology (2023)
Yuka Nojiri, Motoki Nakamura, Tetsuya Magara, Aya Yamamoto, Kyoko Ikumi, Reiko Nakamura, Emi Nishida, Thomas Haarmann-Stemmann, Akimichi Morita
Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients. Scientific reports 13 (1) (2023)
Akimichi Morita, Hidehisa Saeki
Pediatric psoriasis: Understanding pathological conditions and advances in treatment. The Journal of dermatology 51 (2) (2023)
Masanari Niwa, Natsuo Tomita, Taiki Takaoka, Hirota Takano, Chiyoko Makita, Masayuki Matsuo, Sou Adachi, Yukihiko Oshima, Shintaro Yamamoto, Mayu Kuno, Akifumi Miyakawa, Dai Okazaki, Akira Torii, Nozomi Kita, Seiya Takano, Motoki Nakamura, Hiroshi Kato, Akimichi Morita, Akio Hiwatashi
Clinical Outcomes of Radiation Therapy for Angiosarcoma of the Scalp and Face: A Multi-Institutional Observational Study. Cancers 15 (14) (2023)
Kazuhiro Toriyama, Hiroshi Kato, Hideyoshi Sato, Tomoyo Tanaka, Masukazu Inoie, Akimichi Morita
Using minigraft outcomes to predict cultured epidermal autograft success. The Journal of dermatology (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
A David Burden, Robert Bissonnette, Alexander A Navarini, Masamoto Murakami, Akimichi Morita, Thomas Haeufel, Binqi Ye, Frank Baehner, Tadashi Terui
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatology and therapy (2023)
Shinichi Imafuku, Yayoi Tada, Lauren Hippeli, Subhashis Banerjee, Akimichi Morita, Mamitaro Ohtsuki
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial. The Journal of dermatology (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Kyoka Otake, Motoki Nakamura, Yuki Enomoto, Mai Sakurai, Yua Nakagawa, Aya Yamamoto, Yoshiko Oshima, Arisa Asano, Shinsuke Iida, Akimichi Morita
Specific dermoscopic findings in glomeruloid haemangioma for diagnosis of POEMS syndrome. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Yuka Nojiri, Motoki Nakamura, Tetsuya Magara, Aya Yamamoto, Kyoko Ikumi, Reiko Nakamura, Emi Nishida, Thomas Haarmann-Stemmann, Akimichi Morita
Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients. Scientific reports 13 (1) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Thierry Passeron, H W Lim, C L Goh, H Y Kang, F Ly, Akimichi Morita, Jorge Ocampo Candiani, S Puig, S Schalka, L Wei, A-L Demessant-Flavigny, C Le Floc'h, D Kerob, Brigitte Dreno, Jean Krutmann
Sun exposure behaviors as a compromise to paradoxical injunctions: Insight from a worldwide survey. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Alexander A Navarini, Jörg C Prinz, Akimichi Morita, Tsen Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Alexander A Navarini, Jörg C Prinz, Akimichi Morita, Tsen Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology (2022)
Akimichi Morita, Chiharu Tateishi, Kyoko Ikumi, Daisuke Hayashi, Aya Nakada, Haruna Nishihara, Kan Torii, Emi Nishida, Daisuke Tsuruta
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma. Dermatology and therapy 12 (3) (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Akimichi Morita, Tsen Fang Tsai, Evelyn Yap Wen Yee, Yukari Okubo, Shinichi Imafuku, Min Zheng, Ling Li, Manuel Quaresma, Christian Thoma, Siew Eng Choon
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study. The Journal of dermatology (2022)
Alexander A Navarini, J C Prinz, Akimichi Morita, Tsen Fang Tsai, M-A Viguier, L Li, C Thoma, M Sivalingam, M G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Akihiro Matsubara, Naomi Tsuchida, Mai Sakurai, Ayaka Maeda, Yuri Uchiyama, Kaneshige Sasaki, Yoichiro Haji, Yohei Kirino, Naomichi Matsumoto, Akimichi Morita
A case of VEXAS syndrome with Sweet's disease and pulmonary involvement. The Journal of dermatology 49 (5) (2022)
Kyoko Ikumi, Kan Torii, Tomohiko Kio, Hideyuki Masuda, Yoshifumi Kanayama, Akimichi Morita
A case of mycosis fungoides effectively treated with ultraviolet light A 1-light-emitting diode phototherapy. Photodermatology, photoimmunology & photomedicine (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology (2022)
Akimichi Morita, Siew Eng Choon, Hervé Bachelez, Milan J Anadkat, Slaheddine Marrakchi, Min Zheng, Tsen-Fang Tsai, Hamida Turki, Harry Hua, Sushmita Rajeswari, Christian Thoma, A David Burden
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis. Dermatology and therapy (2022)
Yukiko Yasui, Hiroshi Kato, Takao Oda, Motoki Nakamura, Akimichi Morita
Complications and risk factors of punch biopsy: A retrospective large-scale study. The Journal of dermatology (2022)
Keisuke Ono, Kishimoto Mitsumasa, Gautam A Deshpande, Sho Fukui, Satoshi Kawaai, Haruki Sawada, Minoru Matsuura, Valeria Rios Rodriguez, Fabian Proft, Kurisu Tada, Naoto Tamura, Yoshinori Taniguchi, Ayako Hirata, Hideto Kameda, Shigeyoshi Tsuji, Yuko Kaneko, Hiroaki Dobashi, Tadashi Okano, Yoichiro Haji, Akimichi Morita, Masato Okada, Yoshinori Komagata, Clementina López Medina, Anna Moltó, Maxime Dougados, Tadakazu Hisamatsu, Tetsuya Tomita, Shinya Kaname
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatology international 42 (10) (2022)
Jörg C Prinz, Siew Eng Choon, Christopher Ernest Maitland Griffiths, Joseph Frank Merola, Akimichi Morita, Darren M Ashcroft, Manuelle Viguier
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Akimichi Morita, Kiyohiro Nishikawa, Fumika Yamada, Keiichi Yamanaka, Hideki Nakajima, Mamitaro Ohtsuki
Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis. The Journal of dermatology 49 (10) (2022)
Alexander A Navarini, Jörg C Prinz, Akimichi Morita, Tsen Fang Tsai, Manuelle-Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam, Mark G Lebwohl
Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Akimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, Kyoko Ikumi, Aya Yamamoto, Haruna Nishihara, Daisuke Hayashi, Yukihiko Watanabe, Yuko Watanabe, Ayano Maruyama, Koji Masuda, Daisuke Tsuruta, Norito Katoh
Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris. The Journal of dermatology 49 (12) (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Kan Torii, Yukinori Okada, Akimichi Morita
Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops. Scientific reports 11 (1) (2021)
Motoki Nakamura, Akimichi Morita
Immune activity in Merkel cell carcinoma. The Journal of dermatology (2021)
Hiroaki Shime, Mizuyu Odanaka, Makoto Tsuiji, Takuma Matoba, Masaki Imai, Yoshiaki Yasumizu, Ryuta Uraki, Kiyoshi Minohara, Maiko Watanabe, Anthony John Bonito, Hidehiro Fukuyama, Naganari Ohkura, Shimon Sakaguchi, Akimichi Morita, Sayuri Yamazaki
Reply to Slominski et al.: UVB irradiation induces proenkephalin+ regulatory T cells with a wound-healing function. Proceedings of the National Academy of Sciences of the United States of America 118 (3) (2021)
Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Shinichi Imafuku, Yayoi Tada, Masaru Honma, Alan M Mendelsohn, Masaki Kawamura, Mamitaro Ohtsuki
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Toshihisa Hamada, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Noriko Makita, Katsunori Manaka, Yoshihito Shimoyama, Makoto Sugaya
Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance. The Journal of dermatology (2021)
Mayumi Komine, Akimichi Morita
Generalized pustular psoriasis: current management status and unmet medical needs in Japan. Expert review of clinical immunology 17 (9) (2021)
Mai Sakurai, Motoki Nakamura, Kyoko Ikumi, Hiroshi Kato, Akimichi Morita
Dermoscopic findings of psoralen and ultraviolet A therapy lentigines resembling melanoma in a patient with mycosis fungoides. The Journal of dermatology 48 (11) (2021)
Yukari Okubo, Nirali Kotowsky, Ran Gao, Kumiko Saito, Akimichi Morita
Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database. The Journal of dermatology 48 (11) (2021)
Akimichi Morita, Nirali Kotowsky, Ran Gao, Reiko Shimizu, Yukari Okubo
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database. The Journal of dermatology 48 (10) (2021)
Yoichi Shintani, Emi Nishida, Takuya Furuhashi, Shinnosuke Muramatsu, Ryoji Kubo, Motoki Nakamura, Shoichi Watanabe, Hideyuki Masuda, Kyoko Ikumi, Kazuhiko Matsumoto, Sayuri Yamazaki, Akimichi Morita
Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases. The Journal of dermatology (2021)
Takao Oda, Hiroshi Kato, Motoki Nakamura, Akimichi Morita
Analysis of biomonitoring data after full-thickness skin grafting. The Journal of dermatology 48 (7) (2021)
Kyoko Ikumi, Kan Torii, Yoko Sagawa, Yoshifumi Kanayama, Aya Nakada, Haruna Nishihara, Akimichi Morita
Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients. The Journal of dermatology 49 (4) (2021)
Kazuhiro Toriyama, Hiroshi Kato, Hideyoshi Sato, Tomoyo Tanaka, Masukazu Inoie, Akimichi Morita
Cultured epidermal autografts for treatment of stable vitiligo: Quantitative analysis of color matching with surrounding normally pigmented skin. The Journal of dermatology 48 (9) (2021)
Defri Rizaldy, Manami Toriyama, Hiroko Kato, Runa Fukui, Fumitaka Fujita, Motoki Nakamura, Fumihiro Okada, Akimichi Morita, Ken J Ishii
Increase in primary cilia in the epidermis of patients with atopic dermatitis and psoriasis. Experimental dermatology 30 (6) (2021)
Jean Krutmann, Sérgio Schalka, Rachel Elizabeth Beatrice Watson, Liu Wei, Akimichi Morita
Daily photoprotection to prevent photoaging. Photodermatology, photoimmunology & photomedicine 37 (6) (2021)

Akimichi Morita.css-eqlu8i{font-size:small;padding-left:4px;} (A Morita)

Publication Activity (10 Years)

Top Topics

Top Venues

Akimichi Morita (A Morita)